Login
Navigate Fool.com
Will BAX beat
the market?
Community Rating: 5 Stars: The Best

72.81 -0.64 (-0.87%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $73.52
Previous Close $73.45
Daily Range $72.41 - $74.00
52-Week Range $62.80 - $75.68
Market Cap $39.5B
P/E Ratio 19.84
Dividend (Yield) $1.96 (2.7%)
Ex-Dividend Date
Dividend Pay Date
03/05/14
04/01/14
Volume 4,258,274
Average Daily Volume 4,062,702
Current FY EPS $5.16

How do you think BAX
will perform against the market?

Top BAX Bull/Bear Pitches

 

frankinCA (0)
Submitted December 3, 2010

It is another beneficiary of the healthcare and is a low cost provider of hospital IV products that are essential. They are very active in discovering a man made blood replacement for emergency uses, … More

0 Replies Reply Report this Post
 

PopsDaniecki (< 20)
Submitted May 2, 2008

They may be the greatest in the business doing what they are doing but they are still sitting in the middle of the biggest equities bust in a long time and they are going to feel the pain from their h … More

1 Replies Reply Report this Post

News & Commentary

This Week in Biotech: Diabetes Patients Chalk Up 2 Impressive Victories

Legal settlements and victories, an FDA approval, and two positive clinical results take center stage in this holiday-shortened week in the biotech sector.

Sector Update: Healthcare Shares Mixed Pre-Market; UnitedHealth Q1 Earnings Beat

Sector Update: Healthcare

Google, Intel, IBM outlooks to trump earnings results

Can Fresenius Medical Care AG & Co. Get Past Medicare Reimbursement Issues?

Fresenius has significant market share in dialysis, but reimbursement pressures in the U.S. are a significant challenge.

Covidien plc. (COV) Ex-Dividend Date Scheduled for April 03, 2014

A New Frontier for Biogen Idec, Inc.?

Biogen just won FDA approval for Alprolix. Will hemophilia be a big new frontier for the biotech known for its multiple sclerosis drugs?

Analysts Warm To Baxter's Split Announcement

Special Situation Alert: Time to Buy a Biotech Breakup?

Baxter announced it is splitting into two separate businesses

Alarming Spinoff: ADT Debt Soars, Stock Plunges

See More BAX News...

Sector

Healthcare

Industry

Healthcare Information Services

Baxter International, Inc. (BAX) Description

The Company provides medical products and services. Its medical devices, pharmaceuticals and biotechnology assists healthcare professionals and their patients in the treatment of complex medical conditions. Website: http://www.baxter.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks